The global pharmaceutical industry experienced a 40% drop in company filings mentions of cloud in Q2 2023 compared with the previous quarter, with the highest share accounted for by Shanghai Fosun Pharmaceutical (Group) with 36% year-on-year decrease, according to GlobalData’s analysis of over 102 pharmaceutical company filings. GlobalData’s Cloud Computing in Healthcare – Thematic Intelligence report offers a detailed understanding of how Cloud impacts the value chain in the Pharmaceutical sector. It includes market sizing analysis and the leading Cloud adopters and vendors in the market. Buy the report here.
Notably, cloud was one of the most frequently referenced themes in Q2 2023, ranking highest in terms of mentions, ahead of internet of things and sharing economy, according to GlobalData.
Of the top leading companies in the pharmaceutical industry, Shanghai Fosun Pharmaceutical (Group) had the greatest increase in references for cloud in Q2 2023, compared with the previous quarter. GlobalData identified nine cloud-related sentences in the company's filings - 0.7% of all sentences - and a decrease of 36% in Q2 2023 compared with Q2 2022. Biogen’s mentions of cloud to 3 and Hangzhou Tigermed Consulting’s by 83% to 1.
GlobalData’s Company Filings Analytics also applies sentiment weight to reference sentences, based on whether the sentences are positive, negative, or neutral. Starting at 100 in 2020, an index over 100 is more positive. The overall index for cloud in Q2 2023 was 86.
To further understand GlobalData's analysis on Cloud Computing in Healthcare – Thematic Intelligence, buy the report here.